Biogen
Tracked across 5 events · 53 articles · First seen Feb 06, 2026 · Last active Apr 17, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Tech
Biogen collaborated with Stoke Therapeutics on the development of Zorevunersen. The successful early trial results reflect positively on Biogen's involvement in innovative treatments for neurological disorders.
Mar 04, 2026 · 8 articles
Tech
Biogen sells lecanemab (Leqembi), which was included in the Cochrane review. The review's conclusions could negatively affect Biogen's market valuation and the drug's commercial success.
Apr 16, 2026 · 7 articles
Business
Biogen is a partner in the development and commercialization of Lecanemab with Eisai. The preliminary global revenue for Lecanemab was published in conjunction with Biogen's Q4 report.
Feb 06, 2026 · 23 articles
Tech
Biogen is involved in a joint development and commercialization agreement for lecanemab with Eisai, and also participates in the AHEAD 3-45 clinical study. While not a primary presenter at this conference, its association with lecanemab is noted.
Mar 11, 2026 · 8 articles
Regulatory
Biogen is involved in a joint development and commercialization agreement for lecanemab with Eisai, and also participates in the AHEAD 3-45 clinical study.
Feb 09, 2026 · 7 articles
Eisai
partner
↔
Biogen
Eisai and Biogen have a joint development and commercialization agreement for Le
NEWSDESK
Track Biogen live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard